تاسبوجلوتيد

رقم CAS: 275371-94-3
الصيغة الجزيئية: كسنومكسسنومسنسنومكسوسنومك
الوزن الجزيئي: 3339.763
المواصفات: 98٪
المظهر: مسحوق بلوري أبيض

وظيفة
It is a long-acting GLP-1 receptor agonist developed for the treatment of type 2 diabetes.

Description About Taspoglutide
Taspoglutide is a medication that was under development for the treatment of type 2 diabetes. However, as of my knowledge cutoff in September 2021, taspoglutide was not approved for use by regulatory authorities such as the U.S. Food and Drug Administration (FDA). Therefore, there may have been updates or changes regarding its development and availability since then.
Taspoglutide belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). GLP-1 RAs work by mimicking the action of a hormone called glucagon-like peptide-1, which helps regulate blood sugar levels by stimulating insulin release and reducing the production of glucagon.
Clinical trials for taspoglutide showed promising results in terms of improving glycemic control and reducing body weight in patients with type 2 diabetes.